RCC affects 34% of mutation carriers, and most tumors are of chromophobe, oncocytoma, hybrid, or clear cell histology. [2] [3] [4] In addition, nearly 38% and 84% of BHD cases have a history of pneumothorax and fibrofolliculomas, respectively. Pulmonary cysts occur 
Introduction
Birt-Hogg-Dubé syndrome (also known as BHD) is a hereditary condition named after three Canadian doctors who first described it in 1977 -Arthur R. Birt, Georgina R. Hogg, and William J. Dubé. It is a cancer susceptibility syndrome caused by dominantly inherited mutations in the folliculin (FLCN) gene. The affected individuals are at risk of renal cell carcinoma (RCC) and spontaneous pneumothorax associated with lung cysts and white skin papules called fibrofolliculomas. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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For reprints contact: reprints@medknow.com in the majority of adults with BHD syndrome, leading to spontaneous pneumothorax in at least a quarter of the affected individuals. [2, 5, 6] Thyroid nodules have been associated with the BHD phenotype, present in 65% of individuals and 90% of families with the syndrome. [7] However, a connection between BHD and thyroid cancer has not been substantiated. [8] Case Report 
Discussion
BHD is a hereditary condition named after three Canadian doctors who first described it in 1977. The clinical characteristics include cutaneous manifestations (fibrofolliculomas, trichodiscomas/ angiofibromas, perifollicular fibromas, and acrochordons), pulmonary cysts/history of pneumothorax, and various types of renal tumors. [1] Disease severity can vary significantly even within the same family. Skin lesions typically appear during the third and fourth decades of life and typically increase in size and number with age. Lung cysts are mostly bilateral and multifocal; most individuals are asymptomatic but at high risk for spontaneous pneumothorax. [5] There is a 7-fold increased risk for renal tumors that are typically bilateral and multifocal and usually slow growing; median age of tumor diagnosis is 48 years. [4] The most common renal tumors are a hybrid of oncocytoma and chromophobe histologic cell types (the so-called oncocytic hybrid tumor) and chromophobe histologic cell types. Some families have renal tumor and/or autosomal dominant spontaneous pneumothorax without cutaneous manifestations. [5] BHD syndrome is inherited in an autosomal dominant manner. Offspring of an individual with BHD syndrome have a 50% chance of inheriting the pathogenic variant.
Although thyroid nodules have been associated with the BHD phenotype, present in 65% of individuals and 90% of families with the syndrome, no connection between BHD and thyroid cancer has been substantiated. [7, 8] In this case report, we present a patient with no cutaneous manifestation but with bilateral renal tumors and thyroid cancer. Recently, there was a case report of two patients with RCC and dermatological features that were detected with FLCN gene. [9] The two BHD patients were diagnosed with papillary thyroid carcinoma, which was treated with total thyroidectomy and prophylactic bilateral central lymph node dissection. However, in our case, the thyroid pathology was different, consistent with hurtle cell thyroid carcinoma. 18F-FDG PET/CT is not an optimal evaluation tool for renal/urinary tract pathology. However, careful assessment of the CT features in conjunction with the associated metabolic activity of the 18F-FDG PET component increases the diagnostic accuracy of PET/CT.
Conclusion
In our case, 18F-FDG PET/CT study depicted bilateral renal lesions with low/moderate metabolic activity and pulmonary cysts suggestive of BHD syndrome in a patient with right supraclavicular lesion. Although 18F-FDG PET/CT is not an optimal evaluation tool for renal/urinary tract pathology, thorough assessment of both PET and low-dose CT components for detection of renal neoplastic lesions is advised.
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